Zhejiang Taimei Medical Technology Co Ltd Class H

As of December 31, 2025, Zhejiang Taimei Medical Technology Co Ltd Class H carries a market capitalization of 2.23B, placing it among publicly traded companies globally. Its enterprise value stands at 1.05B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Zhejiang Taimei Medical Technology Co Ltd Class H's next confirmed earnings release is scheduled for March 29, 2027.

As of December 31, 2025, Zhejiang Taimei Medical Technology Co Ltd Class H has 563.61M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Zhejiang Taimei Medical Technology Co Ltd Class H maintains a current ratio of 4.48, meaning it holds 4.5x the short-term assets needed to cover near-term liabilities.

As of the close on October 23, 2026, Zhejiang Taimei Medical Technology Co Ltd Class H's stock has gained approximately 1.30% over the past 52 weeks. The 50-day moving average sits at 4.98, while the 200-day moving average is 4.96.

As of December 31, 2025, Zhejiang Taimei Medical Technology Co Ltd Class H holds 1.33B in cash and equivalents against 68.03M in total debt, resulting in a net debt position of -642.34M. Total book value stands at 1.25B, with working capital of 1.27B providing operational flexibility.